{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:17:03Z","timestamp":1789780623958,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Performance of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR Green I fluorescence (MSF) drug sensitivity tests were directly compared using <jats:italic>Plasmodium falciparum<\/jats:italic> reference strains and fresh <jats:italic>ex vivo<\/jats:italic> isolates from Cambodia against a panel of standard anti-malarials. The objective was to determine which of these two common assays is more appropriate for studying drug susceptibility of \u201cimmediate <jats:italic>ex vivo<\/jats:italic>\u201d (IEV) isolates, analysed without culture adaption, in a region of relatively low malaria transmission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using the HRP-2 and MSF methods, the 50% inhibitory concentration (IC<jats:sub>50<\/jats:sub>) values against a panel of malaria drugs were determined for <jats:italic>P. falciparum<\/jats:italic> reference clones (W2, D6, 3D7 and K1) and 41 IEV clinical isolates from an area of multidrug resistance in Cambodia. Comparison of the IC<jats:sub>50<\/jats:sub> values from the two methods was made using Wilcoxon matched pair tests and Pearson\u2019s correlation. The lower limit of parasitaemia detection for both methods was determined for reference clones and IEV isolates. Since human white blood cell (WBC) DNA in clinical samples is known to reduce MSF assay sensitivity, SYBR Green I fluorescence linearity of <jats:italic>P. falciparum<\/jats:italic> samples spiked with WBCs was evaluated to assess the relative degree to which MSF sensitivity is reduced in clinical samples.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>IC<jats:sub>50<\/jats:sub> values correlated well between the HRP-2 and MSF methods when testing either <jats:italic>P<\/jats:italic>. <jats:italic>falciparum<\/jats:italic> reference clones or IEV isolates against 4-aminoquinolines (chloroquine, piperaquine and quinine) and the quinoline methanol mefloquine (Pearson r\u2009=\u20090.85-0.99 for reference clones and 0.56-0.84 for IEV isolates), whereas a weaker IC<jats:sub>50<\/jats:sub> value correlation between methods was noted when testing artemisinins against reference clones and lack of correlation when testing IEV isolates. The HRP-2 ELISA produced a higher overall success rate (90% for producing IC<jats:sub>50<\/jats:sub> best-fit sigmoidal curves), relative to only a 40% success rate for the MSF assay, when evaluating <jats:italic>ex vivo<\/jats:italic> Cambodian isolates. Reduced sensitivity of the MSF assay is likely due to an interference of WBCs in clinical samples.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>For clinical samples not depleted of WBCs, HRP-2 ELISA is superior to the MSF assay at evaluating fresh <jats:italic>P<\/jats:italic>. <jats:italic>falciparum<\/jats:italic> field isolates with low parasitaemia (&lt;0.2%) generally observed in Southeast Asia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-12-239","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T14:14:17Z","timestamp":1373638457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia"],"prefix":"10.1186","volume":"12","author":[{"given":"Suwanna","family":"Chaorattanakawee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanthap","family":"Lon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritsanai","family":"Yingyuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiriya","family":"Ruttvisutinunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siratchana","family":"Sundrakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyaporn","family":"Sai-gnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A","family":"Lanteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,12]]},"reference":[{"key":"2848_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(82)92403-5","volume":"1","author":"KH Rieckmann","year":"1982","unstructured":"Rieckmann KH: Visual in-vitro test for determining the drug sensitivity of Plasmodium falciparum. Lancet. 1982, 1: 1333-1335.","journal-title":"Lancet"},{"key":"2848_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979, 16: 710-718.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4269\/ajtmh.2004.71.711","volume":"71","author":"H Noedl","year":"2004","unstructured":"Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS: A histidine-rich protein 2-based malaria drug sensitivity assay for field use. AmJTrop Med Hyg. 2004, 71: 711-714.","journal-title":"AmJTrop Med Hyg"},{"key":"2848_CR4","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1128\/AAC.46.6.1658-1664.2002","volume":"46","author":"H Noedl","year":"2002","unstructured":"Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C: Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother. 2002, 46: 1658-1664.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR5","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1128\/AAC.01607-06","volume":"51","author":"JD Johnson","year":"2007","unstructured":"Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC: Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007, 51: 1926-1933.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4269\/ajtmh.2011.10-0674","volume":"85","author":"HM Akala","year":"2011","unstructured":"Akala HM, Eyase FL, Cheruiyot AC, Omondi AA, Ogutu BR, Waters NC, Johnson JD, Polhemus ME, Schnabel DC, Walsh DS: Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR green I in vitro assay and molecular analysis. AmJTrop Med Hyg. 2011, 85: 34-41.","journal-title":"AmJTrop Med Hyg"},{"key":"2848_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M: Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004, 48: 1803-1806.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4269\/ajtmh.2010.09-0417","volume":"82","author":"MG Vossen","year":"2010","unstructured":"Vossen MG, Pferschy S, Chiba P, Noedl H: The SYBR green I malaria drug sensitivity assay: performance in low parasitemia samples. AmJTrop Med Hyg. 2010, 82: 398-401.","journal-title":"AmJTrop Med Hyg"},{"key":"2848_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/1475-2875-11-198","volume":"11","author":"SD Tyner","year":"2012","unstructured":"Tyner SD, Lon C, Se Y, Bethell D, Socheat D, Noedl H, Sea D, Satimai W, Schaecher K, Rutvisuttinunt W, Fukuda MM, Chaorattanakawee S, Yingyuen K, Sundrakes S, Chaichana P, Saingam P, Buathong N, Sriwichai S, Chann S, Timmermans A, Saunders DL, Walsh DS: Ex vivo drug sensitivity profiles of plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidinerich protein-2 assay. Malar J. 2012, 11: 198-","journal-title":"Malar J"},{"key":"2848_CR10","doi-asserted-by":"publisher","first-page":"e19283","DOI":"10.1371\/journal.pone.0019283","volume":"6","author":"D Bethell","year":"2011","unstructured":"Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, Darapiseth S, Teja-Isavadharm P, Khemawoot P, Schaecher K, Ruttvisutinunt W, Lin J, Kuntawungin W, Gosi P, Timmermans A, Smith B, Socheat D, Fukuda MM: Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS One. 2011, 6: e19283-","journal-title":"PLoS One"},{"key":"2848_CR11","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1128\/AAC.49.8.3575-3577.2005","volume":"49","author":"H Noedl","year":"2005","unstructured":"Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M: Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005, 49: 3575-3577.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR12","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1086\/657120","volume":"51","author":"H Noedl","year":"2010","unstructured":"Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM, Socheat D, Lon C: Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis. 2010, 51: e82-e89.","journal-title":"Clin Infect Dis"},{"key":"2848_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-4894(83)90091-7","volume":"56","author":"J Le Bras","year":"1983","unstructured":"Le Bras J, Deloron P, Ricour A, Andrieu B, Savel J, Coulaud JP: Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Exp Parasitol. 1983, 56: 9-14.","journal-title":"Exp Parasitol"},{"key":"2848_CR14","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1086\/592506","volume":"198","author":"SL Nsobya","year":"2008","unstructured":"Nsobya SL, Kiggundu M, Joloba M, Dorsey G, Rosenthal PJ: Complexity of Plasmodium falciparum clinical samples from uganda during short-term culture. J Infect Dis. 2008, 198: 1554-1557.","journal-title":"J Infect Dis"},{"key":"2848_CR15","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1128\/AAC.00477-11","volume":"55","author":"S Pelleau","year":"2011","unstructured":"Pelleau S, Bertaux L, Briolant S, Ferdig MT, Sinou V, Pradines B, Parzy D, Jambou R: Differential association of Plasmodium falciparum Na+\/H\u2009+\u2009exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum. Antimicrob Agents Chemother. 2011, 55: 5834-5841.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR16","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/AAC.01313-06","volume":"51","author":"DJ Bacon","year":"2007","unstructured":"Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S: Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob Agents Chemother. 2007, 51: 1172-1178.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.trstmh.2008.01.021","volume":"102","author":"MA Rason","year":"2008","unstructured":"Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D: Performance and reliability of the SYBR green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans R Soc Trop Med Hyg. 2008, 102: 346-351.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2848_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675.","journal-title":"Science"},{"key":"2848_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1475-2875-4-37","volume":"4","author":"W Chaijaroenkul","year":"2005","unstructured":"Chaijaroenkul W, Bangchang KN, Mungthin M, Ward SA: In vitro antimalarial drug susceptibility in Thai border areas from 1998\u20132003. Malar J. 2005, 4: 37-","journal-title":"Malar J"},{"key":"2848_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979, 65: 418-420.","journal-title":"J Parasitol"},{"key":"2848_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1475-2875-11-325","volume":"11","author":"W Rutvisuttinunt","year":"2012","unstructured":"Rutvisuttinunt W, Chaorattanakawee S, Tyner SD, Teja-Isavadharm P, Se Y, Yingyuen K, Chaichana P, Bethell D, Walsh DS, Lon C, Fukuda M, Socheat D, Noedl H, Schaecher K, Saunders DL: Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates. Malar J. 2012, 11: 325-","journal-title":"Malar J"},{"key":"2848_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmpb.2010.08.003","volume":"104","author":"H Le Nagard","year":"2011","unstructured":"Le Nagard H, Vincent C, Mentre F, Le Bras J: Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Comput Methods Programs Biomed. 2011, 104: 10-18.","journal-title":"Comput Methods Programs Biomed"},{"key":"2848_CR23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","volume":"346","author":"JM Bland","year":"1995","unstructured":"Bland JM, Altman DG: Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995, 346: 1085-1087.","journal-title":"Lancet"},{"issue":"Pt 5","key":"2848_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/S0031182099004953","volume":"119","author":"MT Duraisingh","year":"1999","unstructured":"Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC: Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study. Parasitology. 1999, 119 (Pt 5): 435-440.","journal-title":"Parasitology"},{"key":"2848_CR25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4269\/ajtmh.2004.70.474","volume":"70","author":"LK Basco","year":"2004","unstructured":"Basco LK: Molecular epidemiology of malaria in Cameroon. XX. experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. AmJTrop Med Hyg. 2004, 70: 474-480.","journal-title":"AmJTrop Med Hyg"},{"key":"2848_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1128\/JCM.02250-09","volume":"48","author":"S Wein","year":"2010","unstructured":"Wein S, Maynadier M, Tran Van Ba C, Cerdan R, Peyrottes S, Fraisse L, Vial H: Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. J Clin Microbiol. 2010, 48: 1651-1660.","journal-title":"J Clin Microbiol"},{"key":"2848_CR27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.40.4.835","volume":"40","author":"LJ Smeijsters","year":"1996","unstructured":"Smeijsters LJ, Zijlstra NM, Franssen FF, Overdulve JP: Simple, fast, and accurate fluorometric method to determine drug susceptibility of Plasmodium falciparum in 24-well suspension cultures. Antimicrob Agents Chemother. 1996, 40: 835-838.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0035-9203(97)90292-3","volume":"91","author":"V Desakorn","year":"1997","unstructured":"Desakorn V, Silamut K, Angus B, Sahassananda D, Chotivanich K, Suntharasamai P, Simpson J, White NJ: Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma. Trans R Soc Trop Med Hyg. 1997, 91: 479-483.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2848_CR29","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM: Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008, 359: 2619-2620.","journal-title":"N Engl J Med"},{"key":"2848_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/QCO.0b013e32834cd3ed","volume":"24","author":"C O'Brien","year":"2011","unstructured":"O'Brien C, Henrich PP, Passi N, Fidock DA: Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis. 2011, 24: 570-577.","journal-title":"Curr Opin Infect Dis"},{"key":"2848_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0006-2952(90)90302-2","volume":"40","author":"TG Geary","year":"1990","unstructured":"Geary TG, Divo AD, Jensen JB, Zangwill M, Ginsburg H: Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. implications for mechanism of action of and resistance to the drug. Biochem Pharmacol. 1990, 40: 685-691.","journal-title":"Biochem Pharmacol"},{"key":"2848_CR32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/AAC.42.3.682","volume":"42","author":"SR Hawley","year":"1998","unstructured":"Hawley SR, Bray PG, Mungthin M, Atkinson JD, O'Neill PM, Ward SA: Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob Agents Chemother. 1998, 42: 682-686.","journal-title":"Antimicrob Agents Chemother"},{"key":"2848_CR33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.54.1.170","volume":"54","author":"PG Bray","year":"1998","unstructured":"Bray PG, Mungthin M, Ridley RG, Ward SA: Access to hematin: the basis of chloroquine resistance. Mol Pharmacol. 1998, 54: 170-179.","journal-title":"Mol Pharmacol"},{"key":"2848_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1475-2875-8-279","volume":"8","author":"C Moneriz","year":"2009","unstructured":"Moneriz C, Marin-Garcia P, Bautista JM, Diez A, Puyet A: Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia plasmodium infected erythrocytes. Malar J. 2009, 8: 279-","journal-title":"Malar J"},{"key":"2848_CR35","volume-title":"In vitro Module","author":"P. falciparum drug sensitivity assay using SYBR\u00ae Green I Assay Technique WWARN Procedure","year":"2011","unstructured":"P. falciparum drug sensitivity assay using SYBR\u00ae Green I Assay Technique WWARN Procedure: In vitro Module. 2011, WWARN"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:39:36Z","timestamp":1630543176000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2848"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-239","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,12]]},"assertion":[{"value":"2 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"239"}}